Table 2.
Prevalence in % (95% CI) | ||||
---|---|---|---|---|
lifetime usea | current use | past use | willingness to tryb | |
Sex | ||||
Male | 43.8 (35.8–52.0) | 27.5 (20.6–35.2) | 24.2 (17.6–31.8) | 20.3 (14.2–27.5) |
Female | 48.7 (32.4–65.2) | 33.3 (19.1–50.2) | 25.6 (13.0–42.1) | 17.9 (7.5–33.5) |
Age groups (in years) | ||||
18–24 | 44.1 (31.2–57.6) | 20.3 (11.0–32.8) | 32.2 (20.6–45.6) | 10.2 (3.8–20.8) |
25–34 | 40.3 (28.9–52.5) | 30.6 (20.2–42.5) | 18.1 (10.0–28.9) | 20.8 (12.2–32.0) |
≥ 35 | 50.8 (37.7–63.9) | 34.4 (22.7–47.7) | 24.6 (14.5–37.3) | 27.9 (17.1–40.8) |
Diagnoses | ||||
Other ASD diagnosis | 42.0 (31.1–53.5) | 28.4 (18.9–39.5) | 22.2 (13.7–32.8) | 21.0 (12.7–31.5) |
Asperger syndrome | 46.8 (37.3–56.6) | 28.8 (20.6–38.2) | 26.1 (18.2–35.3) | 18.9 (12.1–27.5) |
Intellectual functioning | ||||
IQ < 85 | 42.6 (29.2–56.8) | 31.5 (19.5–45.6) | 25.9 (15.0–39.7) | 16.7 (7.9–29.3) |
IQ ≥ 85 | 42.7 (33.9–51.9) | 27.4 (19.8–36.2) | 21.0 (14.2–29.2) | 21.0 (14.2–29.2) |
Level of education | ||||
Low | 44.6 (31.3–58.5) | 32.1 (20.3–46.0) | 25.0 (14.4–38.4) | 17.9 (8.9–30.4) |
Medium | 41.2 (27.6–55.8) | 23.5 (12.8–37.5) | 27.5 (15.9–41.7) | 9.8 (3.3–21.4) |
High | 47.1 (36.1–58.2) | 29.4 (20.0–40.3) | 22.4 (14.0–32.7) | 27.1 (18.0–37.8) |
Overall | 44.8 (37.6–52.1) | 28.6 (22.4–35.6) | 24.5 (18.6–31.2) | 19.8 (14.4–26.1) |
acontains all respondents who stated current use, past use or both
bcontains also respondents who stated that they already use or have used some other CAM modality